FDA Inspection 1265748 — Apotex Research Private Limited

Apotex Research Private Limited — FEI 3007078919

The FDA completed an inspection of Apotex Research Private Limited on December 13, 2024 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 13, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bangalore (India)

Additional Details

Bioanalytical BA/BE